RadNet (RDNT) Competitor Comparison
We are evaluating the key criteria listed to compare RadNet (RDNT) against its competitors in the Diagnostics & Research industry.
Market Capitalization
25 / 58Gross Profits
27 / 52Total Revenue
20 / 57EBITDA
22 / 56Free Cashflow
20 / 56Quick Ratio
34 / 57Earnings per Share
22 / 56Dividend yield
0 / 9Total Cash
18 / 57Performance 3 years
3 / 58Performance 5 years
2 / 58Performance 10 years
4 / 58Linearity 3 years
58 / 58Linearity 5 years
58 / 58Linearity 10 years
55 / 58Total Rank
10 / 58Dividend Rank
32 / 58Valuation Rank
11 / 58Piotroski Rank
28 / 58Muliplier Rank
15 / 58Linearity 5 years - RDNT ranking 58 / 58
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.